Knoxville Biz Ticker: BESCO announces new President
The Knoxville News-Sentinel 2 hrs ago Knoxville News Sentinel
BESCO promotes Bridgett McMahan to President
Knoxville, Tennessee – May 11, 2021 – BESCO, an industry leader in providing electrical and mechanical services throughout the Southeast region and across the United States, today announced the promotion of Bridgett McMahan to President. McMahan joined BESCO six years ago and is currently BESCO’s Vice President of
Administration, overseeing its legal, compliance, HR, marketing, and IT departments.
According to BESCO CEO, Wayne Wojciechowski, “I am very excited about this promotion. Bridgett is a proven leader and has both the experience and knowledge of our business to keep us growing in the future. More importantly, she is a team player, has a real passion for our customers, and cares deeply about everyone at BESCO.” He added, “She has earned the respect of her colleagues during her six ye
Knoxville Biz Ticker: New Roadside Eats at Pilot Flying J with Classic and Spicy Chicken Sandwiches
The Knoxville News-Sentinel 2 days ago Knoxville News Sentinel
New Roadside Eats at Pilot Flying J with Classic and Spicy Chicken Sandwiches
KNOXVILLE, Tenn. (May 20, 2021) – Pilot Flying J, the largest network of travel centers in North America, is unveiling two new delicious crispy chicken sandwiches to its growing menu as more Americans are expected to hit the roads this summer. Available now at more than 300 participating Pilot and Flying J Travel Centers across the country, the Southern Chicken Sandwich and Spicy Chicken Sandwich have the flavor and quality ingredients to rival some of the top food brands.
Q BioMed Insider to Invest up to $30M in the Company
Aedesius Holdings Ltd. (AedesiusOne), a privately held global disruption aggregator, enters Into $30M Securities Purchase Agreement with Q BioMed
Up front investment of up to $20M with an optional $10M in 6 month warrants
Proceeds may be used for deploying contract sales force, advancing pipeline, redeeming outstanding convertible debt and convertible preferred shares and acquiring later-stage asset(s)
News provided by
Share this article
QBIO), announced today that it has signed a securities purchase agreement ( Transaction ) with Aedesius Holdings Ltd (AedesiusOne), a privately owned United Kingdom based healthcare and technology aggregator. AedesiusOne is run by Geoffrey Fatzinger, our Global Head of Regulatory Affairs. The agreement gives AedesiusOne the opportunity to buy approximately 43% of the outstanding QBIO shares for an aggregate of $30,000,000. The Transaction is structured as an initial investment of $5,000,000
Knoxville Biz Ticker: Food City to hire 1,000 associates
The Knoxville News-Sentinel 13 hrs ago Knoxville News Sentinel
Food City to hire 1,000 associates
On Wednesday, May 19th, Food City will be hosting a company-wide hiring event to include both full-time and part-time positions. The event will be held at all Food City locations & Food City Distribution Center, 10:00 a.m. – 7:00 p.m.
Food City is planning to hire over 1,000 friendly, smiling faces to work at their Distribution Center and in key customer and food service positions at store locations throughout their operation area. The positions include, both entry-level positions and experienced, skilled positions, such as meat cutter, cake decorator, and retail management, as well as various warehousing/distribution positions.
Citius Pharmaceuticals to Participate in Fireside Chat at the Gabelli Funds Virtual Microcap Symposium on Tuesday, May 18
Citius to highlight corporate strategy and key pipeline assets Mino-Lok® and NC i-MSC
News provided by
Share this article
Share this article
CRANFORD, N.J., May 11, 2021 /PRNewswire/ Citius Pharmaceuticals, Inc. ( Citius or the Company ) (Nasdaq: CTXR) today announced that it will participate in a fireside chat at the Gabelli Funds Virtual Microcap Symposium.
Event Details:
Investors may register for the conference at the event website.
Citius President and Chief Executive Officer Myron Holubiak will focus on the execution of corporate strategy and capital deployment as the Company advances key pipeline assets including Mino-Lok®, a late-stage antibiotic lock solution for the treatment of patients with catheter-related bloodstream infections (CRBSIs), and NC